Day: December 21, 2021

Jaguar Health Announces FDA Conditional Approval of Canalevia-CA1 (Crofelemer), the First and Only Treatment for Chemotherapy-Induced Diarrhea (CID) in Dogs to Receive Any Type of Approval from FDA

By prescription only, Canalevia™-CA1 is a canine-specific formulation of crofelemer, Jaguar's novel, oral plant-based product sustainably harvested from the Croton...

LeanTaaS Named a ‘Flagship Vendor’ for Operational Excellence in Chilmark Research Market Trends Report on Augmented Intelligence for Healthcare Operations

Report cites LeanTaaS as the leader in both market execution and product capabilities among all rated vendors SANTA CLARA, Calif.--(BUSINESS...

error: Content is protected !!